Harvard Doctors:
if a researcher is taking money from a drug company while also receiving federal dollars to research that company's product...Bloomberg 06.Jun.08"He single-handedly put pediatric bipolar disorder on the map," Diller said in a telephone interview yesterday.
The number of kids diagnosed as bipolar increased 40-fold between 1994 and 2003, according to a recent study. Sales of drugs used to treat the condition doubled from 2003 to 2006.
[...]
According to Grassley, the three researchers initially disclosed receiving less than $80,000 from Lilly, the maker of Zyprexa, an antipsychotic, and Strattera, a drug used to treat attention deficit disorder. On further review, in March, they said they had received $172,198 while the company told Grassley it had paid the three a total of $259,756.
Biederman initially said he had gotten less than $10,000 from Johnson & Johnson, the maker of the antipsychotic Risperdal. In March, he said the amount was $5,500. The company told Grassley it paid Biederman $64,378.
via
